vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $194.8M, roughly 1.1× TOMPKINS FINANCIAL CORP). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs 8.3%, a 41.1% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $31.9M). Over the past eight quarters, TOMPKINS FINANCIAL CORP's revenue compounded faster (63.6% CAGR vs 19.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.
COLL vs TMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $194.8M |
| Net Profit | $17.0M | $96.2M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 71.7% |
| Net Margin | 8.3% | 49.4% |
| Revenue YoY | 12.9% | 152.7% |
| Net Profit YoY | 35.3% | 388.9% |
| EPS (diluted) | $0.48 | $6.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $194.8M | ||
| Q3 25 | $209.4M | $87.4M | ||
| Q2 25 | $188.0M | $82.6M | ||
| Q1 25 | $177.8M | $81.7M | ||
| Q4 24 | $181.9M | $77.1M | ||
| Q3 24 | $159.3M | $76.6M | ||
| Q2 24 | $145.3M | $72.7M | ||
| Q1 24 | $144.9M | $72.8M |
| Q4 25 | $17.0M | $96.2M | ||
| Q3 25 | $31.5M | $23.7M | ||
| Q2 25 | $12.0M | $21.5M | ||
| Q1 25 | $2.4M | $19.7M | ||
| Q4 24 | $12.5M | $19.7M | ||
| Q3 24 | $9.3M | $18.6M | ||
| Q2 24 | $19.6M | $15.7M | ||
| Q1 24 | $27.7M | $16.9M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | 71.7% | ||
| Q3 25 | 29.7% | 35.6% | ||
| Q2 25 | 18.7% | 34.2% | ||
| Q1 25 | 12.2% | 31.6% | ||
| Q4 24 | 20.9% | 33.4% | ||
| Q3 24 | 21.9% | 32.0% | ||
| Q2 24 | 32.7% | 28.3% | ||
| Q1 24 | 34.1% | 30.4% |
| Q4 25 | 8.3% | 49.4% | ||
| Q3 25 | 15.0% | 27.1% | ||
| Q2 25 | 6.4% | 26.0% | ||
| Q1 25 | 1.4% | 24.1% | ||
| Q4 24 | 6.9% | 25.5% | ||
| Q3 24 | 5.9% | 24.3% | ||
| Q2 24 | 13.5% | 21.6% | ||
| Q1 24 | 19.1% | 23.2% |
| Q4 25 | $0.48 | $6.72 | ||
| Q3 25 | $0.84 | $1.65 | ||
| Q2 25 | $0.34 | $1.50 | ||
| Q1 25 | $0.07 | $1.37 | ||
| Q4 24 | $0.36 | $1.39 | ||
| Q3 24 | $0.27 | $1.30 | ||
| Q2 24 | $0.52 | $1.10 | ||
| Q1 24 | $0.71 | $1.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $132.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $938.4M |
| Total Assets | $1.7B | $8.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $132.8M | ||
| Q3 25 | $285.9M | $193.5M | ||
| Q2 25 | $222.2M | $212.6M | ||
| Q1 25 | $197.8M | $193.1M | ||
| Q4 24 | $162.8M | $134.4M | ||
| Q3 24 | $120.0M | $132.3M | ||
| Q2 24 | $271.6M | $70.9M | ||
| Q1 24 | $318.0M | $57.1M |
| Q4 25 | $301.7M | $938.4M | ||
| Q3 25 | $274.8M | $788.8M | ||
| Q2 25 | $232.2M | $761.8M | ||
| Q1 25 | $234.4M | $741.4M | ||
| Q4 24 | $228.8M | $713.4M | ||
| Q3 24 | $234.3M | $719.9M | ||
| Q2 24 | $216.6M | $674.6M | ||
| Q1 24 | $222.2M | $667.9M |
| Q4 25 | $1.7B | $8.7B | ||
| Q3 25 | $1.6B | $8.5B | ||
| Q2 25 | $1.6B | $8.4B | ||
| Q1 25 | $1.6B | $8.2B | ||
| Q4 24 | $1.7B | $8.1B | ||
| Q3 24 | $1.6B | $8.0B | ||
| Q2 24 | $1.1B | $7.9B | ||
| Q1 24 | $1.1B | $7.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $38.9M |
| Free Cash FlowOCF − Capex | $122.4M | $31.9M |
| FCF MarginFCF / Revenue | 59.6% | 16.4% |
| Capex IntensityCapex / Revenue | 0.3% | 3.6% |
| Cash ConversionOCF / Net Profit | 7.25× | 0.40× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $105.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $38.9M | ||
| Q3 25 | $78.4M | $34.9M | ||
| Q2 25 | $72.4M | $18.9M | ||
| Q1 25 | $55.4M | $22.2M | ||
| Q4 24 | $84.6M | $95.0M | ||
| Q3 24 | $-9.0M | $21.2M | ||
| Q2 24 | $67.4M | $27.3M | ||
| Q1 24 | $61.9M | $23.2M |
| Q4 25 | $122.4M | $31.9M | ||
| Q3 25 | $78.3M | $33.9M | ||
| Q2 25 | $72.4M | $18.3M | ||
| Q1 25 | $54.6M | $20.9M | ||
| Q4 24 | $84.1M | $88.8M | ||
| Q3 24 | $-9.2M | $18.9M | ||
| Q2 24 | $67.1M | $26.3M | ||
| Q1 24 | $61.4M | $21.9M |
| Q4 25 | 59.6% | 16.4% | ||
| Q3 25 | 37.4% | 38.8% | ||
| Q2 25 | 38.5% | 22.1% | ||
| Q1 25 | 30.7% | 25.5% | ||
| Q4 24 | 46.2% | 115.1% | ||
| Q3 24 | -5.8% | 24.7% | ||
| Q2 24 | 46.2% | 36.2% | ||
| Q1 24 | 42.3% | 30.0% |
| Q4 25 | 0.3% | 3.6% | ||
| Q3 25 | 0.1% | 1.1% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.4% | 1.7% | ||
| Q4 24 | 0.3% | 8.1% | ||
| Q3 24 | 0.2% | 2.9% | ||
| Q2 24 | 0.2% | 1.3% | ||
| Q1 24 | 0.4% | 1.9% |
| Q4 25 | 7.25× | 0.40× | ||
| Q3 25 | 2.49× | 1.47× | ||
| Q2 25 | 6.05× | 0.88× | ||
| Q1 25 | 22.92× | 1.13× | ||
| Q4 24 | 6.75× | 4.82× | ||
| Q3 24 | -0.96× | 1.14× | ||
| Q2 24 | 3.44× | 1.74× | ||
| Q1 24 | 2.23× | 1.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
